Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06954142 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia

Study acronym: RELIEF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators: 1 to 2v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 8 to 9
    • Start date changed from estimate of Jul 2025 to Jul 12, 2025
    v3
  3. Primary endpoint revisedv2 Show 6 more changesShow less
    • Enrollment target: 700 to 750
    • Study sites: 1 to 8
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 2 of 11 entries
    • Study description expanded, about 61 words
    • Collaborators expanded, about 3 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to determine whether restricted fluid intake (135 ±5 mL/kg/day) compared to liberal fluid intake (165 ±5 mL/kg/day) from day 8 of life reduces the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age or prior death in preterm infants born \<30 weeks gestational age.
Trial Details
NCT Number NCT06954142
Lead Sponsor University Children's Hospital Basel
Collaborators: Swiss Neonatal Network, SwissPedNet
Conditions
(from sponsor)		 Bronchopulmonary Dysplasia
Related terms Bronchopulmonary Dysplasia
Enrollment 750 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov